Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Geron Corporation

GERN
Current price
4.29 USD -0.21 USD (-4.67%)
Last closed 4.27 USD
ISIN US3741631036
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 477 491 712 USD
Yield for 12 month +131.89 %
1Y
3Y
5Y
10Y
15Y
GERN
21.11.2021 - 28.11.2021

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California. Address: 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.17 USD

P/E ratio

Dividend Yield

Current Year

+237 000 USD

Last Year

+596 000 USD

Current Quarter

+882 000 USD

Last Quarter

+304 000 USD

Current Year

-795 999 USD

Last Year

-272 000 USD

Current Quarter

+436 000 USD

Last Quarter

+29 000 USD

Key Figures GERN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -226 772 992 USD
Operating Margin TTM -7860.88 %
PE Ratio
Return On Assets TTM -32.87 %
PEG Ratio -2.38
Return On Equity TTM -72.56 %
Wall Street Target Price 7.17 USD
Revenue TTM 1 373 000 USD
Book Value 0.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2941.4 %
Dividend Yield
Gross Profit TTM -93 668 000 USD
Earnings per share -0.35 USD
Diluted Eps TTM -0.35 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GERN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GERN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1058:1000
Payout Ratio
Last Split Date 22.07.2014
Dividend Date

Stock Valuation GERN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1603.64
Price Sales TTM 1804.4368
Enterprise Value EBITDA -9.0637
Price Book MRQ 8.078

Financials GERN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GERN

For 52 weeks

1.64 USD 5.34 USD
50 Day MA 4.34 USD
Shares Short Prior Month 81 026 444
200 Day MA 3.74 USD
Short Ratio 9.74
Shares Short 78 825 285
Short Percent 13.15 %